Implantable Loop Recorders Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Implantable Loop Recorders Market was valued at around USD 1.4 billion in 2023 and is estimated to register a CAGR of 8.2% over the forecast period. This robust market growth can be attributed to various factors, including ongoing advancements in implantable loop recorder (ILR) technology, increasing prevalence of cardiac arrhythmias, rising demand for remote monitoring solutions, growing awareness about cardiac health, and the continual growth of healthcare expenditure, among other contributing factors.
Implantable loop recorders (ILR) are a small, implantable medical device designed to continuously monitor and record the electrical activity of the heart over an extended period. It is typically used for the diagnosis and monitoring of cardiac arrhythmias, including atrial fibrillation, bradycardia, tachycardia, and syncope (fainting). The increasing prevalence of cardiac arrhythmias, such as atrial fibrillation, ventricular arrhythmias, and bradyarrhythmias is driving up demand for ILRs. The demand for efficient diagnostic and monitoring methods to identify and treat arrhythmias growing owing to the aging global population and a rising incidence of cardiovascular disease. For instance, according to the American Heart Association, Inc. approximately 3 to 6 million Americans suffer with atrial fibrillation, and by 2050, the number is anticipated to rise to 6 to 16 million. Hence ILRs are becoming an essential device in cardiac care.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Implantable Loop Recorders Market size in 2023: | USD 1.4 Billion |
Forecast Period: | 2024 – 2032 |
Forecast Period 2023 - 2032 CAGR: | 8.2 |
2023 Value Projection: | USD 2.9 Billion |
Historical Data for: | 2018 – 2023 |
No of Pages: | 100 |
Tables, Charts & Figures: | 203 |
Segments Covered: | Product Type, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
Furthermore, continuous advancements in ILR technology have led to the development of smaller, more sophisticated devices with enhanced monitoring capabilities. Improved battery life, wireless connectivity, and remote monitoring features have made ILRs more convenient for both patients and healthcare providers. As technology continues to evolve, ILRs are becoming more reliable, accurate, and user-friendly, driving their adoption in clinical practice, thereby contributing to the market growth.
The implantable loop recorders industry is experiencing several notable trends that are shaping its growth and development. Factors such as technological innovation in ILR design, growing adoption of remote monitoring and telemedicine solutions, rising prevalence of cardiovascular disease, and surging demand for integrated artificial intelligence (AI) in healthcare and machine learning, among other factors are propelling the industry growth.
The market by product type is categorized into automatic recorders and manual recorders. The automatic recorders segment garnered USD 958.6 million revenue in 2023.
Based on application, the implantable loop recorders market is segmented into atrial fibrillation, cardiac syncope, cardiac arrhythmia, and other applications. The atrial fibrillation segment dominated the market and accounted for over 42.3% market share in 2023 and is anticipated to witness significant growth during the forecast period.
The implantable loop recorders industry by end-use is categorized into hospitals, cardiac centers, ambulatory surgical centers, and other end-users. The hospitals segment accounted for around USD 814.4 million revenue size in 2023.
North America implantable loop recorders market accounted for USD 536.7 million revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
The implantable loop recorders industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy.
Some of the eminent market participants operating in the implantable loop recorders industry include:
Implantable loop recorders market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 – 2032 for the following segments:
Market, By Product Type
Market, By Application
Market, By End-use
The above information is provided for the following regions and countries:
North America market accounted for USD 536.7 million in 2023 and is predicted to grow substantially through 2032, owing to a high prevalence of cardiovascular disease, including cardiac arrhythmias such as atrial fibrillation, ventricular tachycardia, and bradyarrhythmias.
Abbott Laboratories, Angel Medical Systems, Inc., Biotronik, Boston Scientific Corporation, GE Healthcare, Koninklijke Philips N.V., Medtronic plc, MicroPort Scientific Corporation, Nihon Kohden Corporation, Vectorious are some of the major industry contenders.
The global market size for implantable loop recorders was valued at around USD 1.4 billion in 2023 and is estimated to reach over USD 2.9 million by 2032, attributed ongoing advancements in implantable loop recorder (ILR) technology and increasing prevalence of cardiac arrhythmias.
Automatic recorders segment of implantable loop recorders industry garnered USD 958.6 million revenue in 2023 and is expected to grow swiftly till 2032, as they enhance diagnostic accuracy by continuously monitoring the heart's electrical activity, enabling the detection of asymptomatic or infrequent arrhythmias that conventional methods may miss.